Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
A549 cells were lysed 72 hours after transfection. Cells were transfected with Transfection Reagent alone (Lane 1), 100nM ON-TARGETplus siCONTROL Non-Targeting Pool (Lane 2), or 100nM ONTARGETplus CDK6 siRNA (Lane 3). Western blot data for CyclophilinB is included as a control for equal protein loading.
|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Human, Mouse, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified recombinant cdk6 protein|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
|Immunoprecipitation (IP)||2 µg/ml|
|Western Blot (WB)||1-2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-13338 targets Cdk6 in IF, IHC (F), IP, and WB applications and shows reactivity with Human, mouse, and Rat samples.
The MA5-13338 immunogen is purified recombinant cdk6 protein.
Cyclin-dependent kinase 6 (p40cdk6 also known as PLSTIRE) belongs to a family of proteins designated as cdks are critical regulators of cell cycle progression. The prototype member of this family, p34cdc2, and a related protein cdk2, function late in the cycle while cdk4 and cdk6 are critically involved in G1 to S progression.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.
MA5-13338 was used in western blot to study the role of MiR-34a in sensitizing bladder cancer cells to cisplatin treatment
|Vinall RL,Ripoll AZ,Wang S,Pan CX,deVere White RW||International journal of cancer (130:2526)||2012|
Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
MA5-13338 was used in western blot to study the opposing roles of cyclin D2 and cyclin D3 in mouse skin carcinogenesis
|Rojas P,Cadenas MB,Lin PC,Benavides F,Conti CJ,Rodriguez-Puebla ML||Oncogene (26:1723)||2007|
|Not Applicable||Not Cited||
p16INK4a-induced senescence is disabled by melanoma-associated mutations.
MA5-13338 was used in immunocytochemistry and western blot to study the effect of melanoma-associated mutations on p16INK4a-induced senescence
|Haferkamp S,Becker TM,Scurr LL,Kefford RF,Rizos H||Aging cell (7:733)||2008|
Cell division protein kinase 6; CR2 protein kinase; CRK2; Cyclin-dependent kinase 6; Serine/threonine-protein kinase PLSTIRE
5830411I20; AI504062; CDK6; CDKN6; Crk2; MCPH12; PLSTIRE